GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
8.56
+1.11 (14.90%)
At close: Oct 8, 2025, 4:00 PM EDT
8.82
+0.26 (3.04%)
After-hours: Oct 8, 2025, 7:30 PM EDT
GlucoTrack Market Cap
GlucoTrack has a market cap or net worth of $7.70 million as of October 8, 2025. Its market cap has decreased by -47.16% in one year.
Market Cap
7.70M
Enterprise Value
-2.68M
1-Year Change
-47.16%
Ranking
Category
Stock Price
$8.56
Market Cap Chart
Since April 25, 2013, GlucoTrack's market cap has decreased from $34.13M to $7.70M, a decrease of -77.44%. That is a compound annual growth rate of -11.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 6.70M | 11.92% |
| Dec 31, 2024 | 5.99M | 9.59% |
| Dec 29, 2023 | 5.46M | -74.96% |
| Dec 30, 2022 | 21.82M | -66.12% |
| Dec 31, 2021 | 64.40M | -9.57% |
| Dec 31, 2020 | 71.22M | -26.72% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |